The high social cost of downsizing the state | Letters

In your report on the mayoral elections in Greater Manchester (Manchester mayor puts focus on homelessness, 9 May) you highlight the financial challenges facing the region, including that local authorities have undergone cuts of around £2bn since 2010. We have just completed a study of the impact of austerity on devolution and growth in Greater Manchester and we find that, in addition to local government cuts, the post-2015 welfare reforms will take almost £13bn from claimants in the region by 2020-21 as a result of benefit cuts and changes. This is the equivalent of £690 per working-age adult per annum. And there are other cuts which devolution has to manage, such as to adult skills and health and social care, where there is a £2bn funding gap.

Andy Burnham’s intention to prioritise homelessness is important and is to be welcomed, but to donate some of his salary to a new fund can send out the wrong message. It is austerity which is reinforcing social inequalities and homelessness in Manchester and elsewhere. We propose that Andy Burnham should argue for a different type of devolution model that is not about devolving austerity, but genuine local control over policies, finances and resources that will realistically address the economic and social problems of Manchester. We argue for a public services and investment case for addressing both growth and social disadvantage, which, combined with more local control over finances, will go some way to addressing not only homelessness, but also poverty and inequality.
Dr David Etherington Middlesex University
Professor Martin Jones Staffordshire University

• The concerns of Hartlepool residents at reductions in police numbers are well founded and regularly featured in over 430 community meetings I have attended in the area since my election in 2012 (Voices and votes, 9 May). The simple facts are that since 2010 the Cleveland area has lost £39m, or 36% of our policing budget, and the government, despite comments on ringfencing police spending, has taken another £1.2m off our grant settlement for this coming year (2017-18). We have implemented economies and efficiencies to maximise investment in neighbourhood policing, and to protect vulnerable people, but it is within a context of seven gruelling years of government-imposed austerity for communities like Hartlepool that impacts on the quality of life here.
Barry Coppinger
Police and Crime Commissioner for Cleveland

• While Polly Toynbee and David Walker are right to bemoan the cuts in services (Disparage, downgrade, downsize, G2, 9 May), surely the underlying issue is how to revive the local state – and in the process restore faith in building a fairer future? This means finding better ways of funding local services, rather than depending on unpredictable government grants. Most of the countries in the OECD do this by raising significantly more funding locally, from cities that cover much larger areas.

This can be achieved quite easily by reforming our anachronistic property rating system. Those with large land ownerships need to pay more, while small businesses, for example, should pay less. As a start councils can use parking charges to shift behaviour, as Nottingham has done in funding a third of the costs of its tram extensions through its workplace parking levy. Similarly, by building many more homes on public land, councils could plough the increases in land value back into improved local services, as Croydon, for example, is starting to do. People may no longer trust the national state to build utopia, but they will support measures that make sense locally.
Dr Nicholas Falk
Executive director, Urbed Trust

• Polly Toynbee and David Walker’s article on shrinking the state was right to mention evidence of rising child poverty. Our recent research shows that Britain has the third worst relative poverty of 21 developed countries, the fourth highest child mortality rate (CMR, 0-4 years) and an underfunded health service, as health expenditure fell from 9.4% of GDP in 2010 to 9.1% in 2015.

While CMR fell in every developed country, nine other nations had significantly bigger reductions than the UK, so we have an excess of child deaths. If we had the same CMR as Portugal, which previously had the highest rate, but which is now considerably lower than Britain, then we would have 1,300 fewer grieving parents. The link between relative poverty and CMR is again confirmed by our and other international research. Every parliamentary candidate should be asked what will they do to reverse relative poverty in Britain and perhaps match Portugal’s child mortality rate.
Professor Colin Pritchard
Bournemouth University

• It is government policy to reduce state spending, but billions of pounds of taxpayers’ money being channelled into private hands. Would a government really committed to lowering taxes and an economy based on free-market competition, spend £10bn a year to subsidise wages in private companies? Why would it be willing to give about £27bn a year to landlords, rather than imposing rent controls or building more homes? Why would it pay through the chancellor’s nose for private finance initiatives, now crippling NHS trusts? Plainly the government is only against state spending when it is on public services, not when it increases the private sector’s ability to make bigger profits.
Derek Heptinstall
Westgate-on-Sea, Kent

• Join the debate – email guardian.letters@theguardian.com

• Read more Guardian letters – click here to visit gu.com/letters

The high social cost of downsizing the state | Letters

Leaflet says Tory win in Copeland will "cost mums their children"

A graphic Labour pamphlet warns voters in Copeland that a Tory victory in the by-election will “cost mums their children” in an open letter aimed at highlighting the risks of NHS cuts in the constituency.

The handwritten letter in support of Labour candidate Gillian Troughton, a St John ambulance driver and former hospital doctor, is from local mother Paula Townsley. The leaflet is the second posted through letterboxes by Labour activists to contain dire warnings about the closures of maternity services at West Cumberland hospital.

Townsley’s letter describes how she gave birth to twins who were 15 weeks premature at West Cumberland hospital, but one of her sons did not survive. Expectant mothers will need to travel more than 40 miles to give birth in Carlisle if the maternity services in the area are closed.

Kevin Schofield (@PolhomeEditor)

Labour really upping the ante in Copeland – a Tory win “will cost mums their children”. pic.twitter.com/VeOtGqSXCd

February 16, 2017

“If I had to travel to Carlisle, I would have lost them both,” she wrote. “West Cumberland hospital has been a lifeline for me and my family.

“The staff still remember my son when he goes in now. They call him the miracle baby. If the Tories are voted in they’ll take it as a green light for the local NHS closures. Their cost-cutting will cost mums their children.

“As a mum to a miracle son, I’m asking you to please vote Labour in our local NHS services on 23 February. It’s only 10 minutes to go to vote for Labour’s Gillian Troughton, but it could save so much.”

The previous Labour byelection leaflet also included a quote from unnamed midwives, warning “mothers will die, babies will die, babies will be brain-damaged”.

Chris Whiteside, who has previously stood for the Conservatives in the seat, said: “I don’t know whether this will help Labour win the Copeland byelection but their tactics on the hospital deserve to lose.”

Labour’s campaign was given a boost on Thursday after negative headlines in the local paper about Theresa May’s visit to the constituency, where she repeatedly refused to answer questions on whether she would back the maternity cuts or over whether the government would underwrite the Moorside nuclear plant, after the Japanese company Toshiba pulled out of the project.

Canvassing is believed to show that Labour has a vote retention in some parts of the constituency as low as 70%.

Few Labour voters are switching directly to the Tories, one Copeland campaign source said, but many have told the party they are opting to stay at home. The party is said to be relying on legwork from the GMB union on the day of the byelection to persuade Sellafield workers to turn out and vote Labour.

Corbyn has confirmed he does not intend to campaign in the constituency again before polling day on 23 February.

The Tory campaign has been hinged on support for nuclear power and the Sellafield plant, a major employer in the area, highlighting Labour leader Jeremy Corbyn’s opposition to nuclear power. Tory leaflets distributed in the constituency feature a quote from Corbyn saying: “I say no nuclear power, decommission the stations we’ve got.”

Leaflet says Tory win in Copeland will "cost mums their children"

NHS commissioners risk losing sight of human cost of their decisions

The revelation that thousands of people could be forced out of their homes into residential care raises serious questions about the judgment of clinical commissioning groups (CCGs).

According to the Health Service Journal story, based on information gathered by campaign group Disability United, at least 37 CCGs have imposed restrictions on access to NHS continuing healthcare funding, which provides ongoing care for adults with a “primary health need”.

Around £2.5bn a year is spent on NHS continuing healthcare, with about 60,000 people receiving support at any one time.

A total of 19 CCGs have said they will not fund care in the person’s own home if it is more than 10% above an alternative – normally going into a care home. The remainder are imposing other restrictions. Up to 13,000 people could be affected among these CCGs; since 87 CCGs did not reply, the national figure could be around 22,000.

Lawyers are wary of a legal challenge, such as under article 8 of the European convention on human rights, which protects the right to family life.

Many of the rationing decisions appear to conflict with the NHS England operating model for NHS continuing healthcare, which says “treating individuals and their families with empathy, respect and dignity is at the core of NHS continuing healthcare delivery”.

Commissioners need some latitude to contain these costs; medical care provided in the home cannot be limitless. But the Department of Health’s guidance stresses that comparative costs have to be balanced against a person’s desire to continue living in their own home.

Overall, Disability United identified 42 CCGs whose responses to Freedom of Information requests on this issue gave cause for concern. In the last performance assessments, NHS England said 20 of them required improvement while nine were rated inadequate – proportionately worse figures than the overall national scores.

That gives little confidence that commissioners pursuing this approach have exhausted all other reasonable options for meeting their budgets.

Of course, this is not straightforward. Many of the choices facing CCGs trying to hit their financial targets are unpalatable, as the growing argument over the threshold for hip and knee replacement surgery demonstrates, while the best solution for some continuing healthcare patients may well be residential care.

But to deprive people of the right to live at home on the basis of a 10% limit on additional cost seems arbitrary and callous. It leaves the uneasy feeling that a vulnerable group of patients – many of the recipients of continuing healthcare have brain injuries, significant disabilities or are dying – are being shunted into a care home because it is an easy saving. In their desperation to find cuts, commissioners are in danger of losing sight of the human cost of their decisions.

Continuing healthcare sits on the fault line between the NHS and social services, and access to it has long been a source of controversy, notably for patients who have had serious strokes. Many families are left baffled by the fine distinctions drawn between medical care on the one hand and social and personal care on the other, understanding only that it is a device for the NHS to shunt costs on to the care system by deciding that the patient’s needs are not primarily medical.

Now it appears that those who are fortunate enough to meet the stringent criteria for continuing healthcare risk being deprived of rights and choices. The underlying problem is that CCGs simply do not have the managerial, analytical or clinical firepower to make care systems lean, efficient and integrated, or to drag funds out of hospitals and into community services, so they are reduced to managing their finances by drawing entirely subjective lines on a spreadsheet that cut patients off from care.

CCG decisions about who can have services such as continuing healthcare, various types of surgery and IVF are dressed up in the language of local choices, but in reality it is largely a matter of luck which cuts commissioners happen to choose. Forcing people to leave their home looks a bad choice.

Join the Healthcare Professionals Network to read more pieces like this. And follow us on Twitter (@GdnHealthcare) to keep up with the latest healthcare news and views.

NHS commissioners risk losing sight of human cost of their decisions

Avocado emergency nearly cost my finger | Letters

I love Claire Ptak’s recipes, but the photograph showing her removing the stone from an avocado – holding the fruit in the palm of her left hand while tapping the stone with the knife held in her right – for her chocolate avocado mousse, made me blanch (Let there be light, Cook, 7 January).

I used this method once after seeing it illustrated in a magazine. The knife went straight through the avocado and nearly cut my finger off, resulting in 11 stitches and plastic surgery on the nerve.

The surgeon told me that there were three types of knife/finger accidents: the oyster-opening one, the avocado one, and the separating-two-frozen-burgers one. A paradigm of the British class system perhaps?
Vivien Bailey
St Albans, Hertfordshire

• Join the debate – email guardian.letters@theguardian.com

• Read more Guardian letters – click here to visit gu.com/letters

Avocado emergency nearly cost my finger | Letters

NHS passport-checking might save a few pence – at the cost of our humanity | Diane Taylor

The most senior official in the Department of Health, Chris Wormald, told MPs yesterday that he was considering asking hospitals to check patients’ passports to find out whether they should be paying for NHS care. In doing so, Wormald may not have been trying to make anti-migrant political capital. But he certainly generated plenty of it.

The implicit message in his disclosure is that we are being overrun with health tourists who are fleecing our cash-strapped NHS and that we must protect what is rightfully ours.

But there were a few things Wormald failed to mention. The number of migrants who pay their way when they use the NHS, for instance, and how many with serious health conditions are denied NHS treatment in a system policed in an increasingly zealous way.

London has the largest number of migrants of any UK city. In 2014, a series of freedom of information requests I made to 20 London hospitals revealed that many had received substantial payments from overseas visitors using the NHS, and that debts from this group of patients were relatively small – too small, perhaps, to justify introducing a vast and expensive new layer of bureaucracy to police and intimidate patients. Many migrants now have to pay a health surcharge and have been doing so since April 2015 as a condition of living here.

What is the definition of a health tourist? Someone who gets on a boat or a plane with the sole purpose of using NHS services on arrival here? Or is it also someone who is in the UK from overseas and then falls ill while they are here?

One man who falls into the latter category is an asylum seeker who was tortured in his home country in west Africa. His asylum claim was refused and he is preparing a fresh bid based on new evidence. He does not qualify for NHS treatment as a refused asylum seeker. In 2013, a charity gave him a bike because he could not afford public transport. He was hit by a car in January 2014 and badly injured. Of course he did not ask to be hit by the car, nor did he plan to use any NHS services at all when he set off on his bike on that fateful day.

As usual with all matters migration, a sense of proportion has been lost here. Populism has tossed morality aside

The London hospital he was admitted to made sure he received nothing more than the basic emergency treatment that everyone is entitled to (although this too may change). He was denied surgery for the chronic and painful injuries he was left with. Since then he has been disabled, in agony and can only walk short distances with the help of a crutch. Yesterday he received a settlement from the insurance company of the driver who injured him. He pursued the claim in order to pay the NHS for the treatment he desperately needs. Although he is destitute, he will be making a net contribution to the NHS.

Another asylum seeker gave birth to twins who were treated for a few days in a special care baby unit. She was sent a bill she could not pay, because as an asylum seeker she is not allowed to work. She is a deeply religious Christian and was so distraught about the bill that she set her alarm at intervals through the night so she could get up and pray that somehow the debt would vanish. She lived in terror of the consequences of not paying the bill. Eventually the NHS wrote off the debt, accepting that as an asylum seeker who is banned from working she could not pay.

The National Audit Office estimates that the uncollected fees are £200m a year, which is around 1% of the current NHS debt. And that figure does not take into account the extra income from those who are paying for their NHS treatment.

As usual with all matters migration, a sense of proportion has been lost here. Populism has tossed morality and ethics out of the window. As Dr Ben White tweeted: “Well, I won’t be asking anyone for their passport before resuscitating them, thanks.”

The hostility towards migrants is piling up. It used to be the job of the Home Office alone to police immigration, but now schools, health professionals, landlords and others have been co-opted, whether they like it or not. Passport checking may save the NHS a few pence as long as the cost of administering such a system does not outweigh these slender savings.

But what is the cost of the humanity we are losing in the process? And what is the deficit in decency and solidarity with other members of the human race? That deficit is piling up and the negative consequences are not just for migrants, but for everyone who inhabits this country.

NHS passport-checking might save a few pence – at the cost of our humanity | Diane Taylor

How to Save Money on the Cost of Natural Health Products

How to Save Money on the Cost of Natural Health Products

The cost of the NHS is a matter of perspective | Letters

The half-truth as you quote Tim Farron as saying about paying for the NHS is that the money has to come out of people’s pockets (Editorial, 21 September). This is not as difficult as it may sound at first if we work out the value to the community of the services provided by the NHS and compare it with the costs. The consistent increase in longevity since 1948 must owe a great deal to its existence, and the addition to the national income year by year must run into billions of pounds if we put a proper value on such things as enabling people to return to work after injury or illness after a shorter absence, or even at all. Reduction in pain and anxiety runs into many more billions, as well as the benefits from improved drugs, new and simpler methods of surgery, treating conditions in outpatients departments, or regular visits to GP surgeries (instead of hospitalisation).

If a monetary value were to be put on these and many other of the NHS’s activities, this would produce a “profit”, year by year. Part of this could then be ploughed back into the service in a similar way to part of commercial and industrial profits being used to finance expansion. It is time to stop nit-picking on the cost side of the NHS and get down to working out just how much we owe it.
Harvey Cole
Winchester, Hampshire

• Raising sufficient revenue to finance our currently strained NHS shouldn’t be a problem economically. When a private company employs more people to produce more goods or services that people clearly need and demand, an appropriate price has to be levied to pay wages and other costs, reimburse lenders and reward shareholders. A private insurance company has to levy premiums on its new customers. In no case is such pricing felt to be an undue imposition with adverse economic effects. Indeed, economists generally consider any such move to have positive multiplier effects on the rest of the economy, as the initial new workers increase demand for general consumer goods.

The same logic surely applies in the case of public services. Provided people really need and demand the services (obviously very much the case) and more service is indeed given (which should be the case if quality workers are employed), then raising revenue through tax or social insurance should have unambiguously good effects. And we can both safely expand essential services and employ good people in well-paid professional and semi-professional public jobs providing these services, more or less to the point that public need and demand is met. If so, this is a massively important (hitherto insufficiently recognised) point that all political parties need to take on board.
Bernard Cummings
Erith, Greater London

State pensioners should make NI contributions according to their ability to pay, writes Alan Baker. Photograph: Henrik Sorensen/Getty

• I stopped paying national insurance contributions when I reached the state pension age 12 years ago. Since then I have needed to make increasing use of the NHS. I have two suggestions for increasing funding for the NHS.

First, require state pensioners to make NI contributions according to their ability to pay. If abolition of the exemption were to be considered ill-advised by political parties fearful that such a measure would lose them votes, then NI contributions could instead be phased out and merged into the income tax system. This approach, less damaging politically, would enable pensioners to contribute to the funding of state pensions and benefits and the NHS fairly, according to their means.

Second, the public need to be better informed about the costs of the NHS, so that we might be more willing to pay for its services. The real cost of a “free” visit to a GP and of “free” common operations such as hip replacements, cataract removals and heart bypasses should be displayed boldly in surgeries and in pharmacies. More of us might then recognise that the NHS provides excellent value for our money – and needs more to meet its understandably rising costs.
Alan Baker
Cambridge

• The Labour leadership have not been as forthcoming as they might about their views on the NHS. Tim Farron sees them as supporting “renationalisation”, which means the current version of the NHS reinstatement bill awaiting its second reading in November. If it were passed into law, £10bn more annually would become available without any increase in taxation, because the current marketised system costs that much more in administration than did the public service model NHS which preceded it (admin costs are now over 14% of the NHS budget instead of the previous 5%).
Jeanne Warren
Oxford

• Your editorial suggests that Jeremy Corbyn’s campaign has failed to provide detail on how he would finance an expanded NHS. This omission is understandable. On the day of his innovative health policy launch in August, the media chose to focus on “traingate” (Report, 25 August). This ludicrous non-news story, which successfully blew away Corbyn’s attempt to publicise his excellent health policy details, involved Richard Branson, whose Virgin Healthcare has a strong commercial interest in eradicating the NHS. What a coincidence.
Catharine Sadler
Little Birch, Herefordshire

• Join the debate – email guardian.letters@theguardian.com

The cost of the NHS is a matter of perspective | Letters

Care home rooms now cost more than £30,000 a year

The financial pressure on older people and their families when trying to pay for social care is growing, with the average cost of a room in a care home now more than £30,000 a year.

The cost of a care home room has risen by 5.2% in the last year, more than 10 times the average increase in pensioners income, according to a report by Prestige Nursing and Care.

The figures highlight the financial crisis in the care home industry and the impact this is having on older people and their families. Four Seasons Health Care, Britain’s biggest care home group, reported a pre-tax loss of £264m last year and that it was struggling under the weight of more than £500m of debt.

The sharp increase in the cost of a room follows the introduction of the “national living wage” in April, which means all workers over 25 must be paid at least £7.20 an hour.

The average annual pensioner’s income of £14,456 would now cover less than six months’ care. The shortfall is equal to £317 a week or £16,470 a year, 9% higher than a year ago. This is despite pensioners enjoying an increase in their income for the last five years, ahead of the average household. The survey by Prestige Nursing does not take into account the value of assets, such as property. It was based on a survey of 165 care homes and official government statistics.

Rising cost of care homes

Rising cost of care homes.

Jonathan Bruce, the managing director of Prestige Nursing, said: “It is particularly alarming that care home costs have risen almost 10 times as much as pensioner incomes in real terms, with the result that older people will find the challenge of paying for care even more out of their reach.”

Care England, which represents care homes, lambasted the government for the crisis in the industry, accusing ministers of not having a strategy for older adult care and allowing local authorities to pay well below the cost of care for residents with state funding.

Martin Green, the chief executive of Care England, said: “I have great sympathy [for residents]. There is a dynamic in this called ageism. Why is it that when you get old and get a disease called dementia, you have to pay for it? I don’t know how in the age of the Equality Act you have older people having to pay for a service that younger people get for free.

“The government needs to have a proper approach to social care. Just pumping money into the NHS isn’t going to work. They need a clear approach, saying that this is what good social care costs. The government needs to show a bit of leadership, I am sick of them hiding behind localism and saying it is about local councils.”

Some local authorities are paying just £330 a week for residents, the equivalent of less than £2 an hour. Industry research has shown that private residents now pay 40% more on average than publicly funded residents for like-for-like service.

Roughly two fifths of care homes residents are private, with another two fifths funded by the state. The remaining residents include those who pay fees but are topped up by local authorities and residents who are funded by the NHS.

Prestige Nursing offers home-care services for older people, but Green said this was not an alternative for people with dementia or other conditions who needed round-the-clock care.

He added: “I think they are pitching to say, ‘People don’t need to be in care homes and we can provide these things much cheaper.’ But actually, these people are in care homes because they can’t be at home.”

Green said it was ridiculous to blame the rising fees and the funding crunch in the industry on private companies. He said state-run social care had been of a “low quality and expensive” before private companies expanded into the market. “The government is not stepping up to the mark,” he added.

Tim Hammond, the chief executive of Four Seasons, said: “It is widely recognised that there is underfunding of social care for both care homes and home care.

“The average local authority weekly fee last year for a care home place was around £560 a week, which equates to about £3.30 an hour to cover 24/7 care, including nursing or dementia care, accommodation, mostly in rooms with en-suite facilities, meals, heating, lighting, laundry.

“As a result of funding constraints, the fees that local authorities pay for care have declined 5% in real terms over the past three or four years. According to independent analysis they are below the fair cost of the care being provided.”

Care home rooms now cost more than £30,000 a year

Must it cost £10 to visit your GP?

The Royal College of Nursing is discussing regardless of whether to back the idea of charging individuals a fee to see their GP.

Final month GPs voted towards a comparable proposal at the British Medical Association’s yearly nearby health-related committee conference.

The British public has previously been observed to be overwhelmingly opposed to the concept of charging at the level of entry.

But some argue that to fund the NHS in the potential new methods of raising income are needed.

What do you feel?

Must it cost £10 to visit your GP?

Nick Xenophon urges floor cost on cigarettes to outsmart tobacco giant

Independent senator Nick Xenophon is pushing for a minimum floor price tag on cigarettes to counter a tobacco giant’s “cynical” move to promote discounted packets.

British American Tobacco Australia has launched what it claims is the cheapest legal packet of cigarettes on the industry at $ 13 for a 25-pack.

It is blaming federal government policy for the move, saying it is merely looking for to remain competitive as income of reduce-cost cigarettes soar.

Xenophon has accused the tobacco giant of circumventing laws to discourage individuals from smoking.

He programs to introduce a resolution in the upper home subsequent week to look for a minimum floor price for all cigarettes offered in Australia.

“We want to outsmart massive tobacco in terms of what they’ve carried out with this value-discounting and reduction-major campaign,” he told ABC Television on Monday.

Xenophon will seek advice from with public overall health authorities on the most effective disincentive price but wants to see a minimum of $ twenty for a 25-pack.

It was the very best choice to fight a “deeply cynical” campaign aimed at boosting the ranks of younger smokers, he stated.

Xenophon also dismissed “exaggerated” market claims that plain packaging laws and huge excises were driving up black market place income.

Nick Xenophon urges floor cost on cigarettes to outsmart tobacco giant

The Cost is Correct: New Hepatitis C Drug is Truly a Priceless Breakthrough

As an infectious disease physician I greet the release of path-breaking new remedies for any infecting pathogen with pleasure. Such innovations represents yet another instance of man’s mind succeeding in the continual war with microbes.

Hepatitis C is a scourge that is the top result in for liver transplantation infecting near to 4 million Americans and above 180 million men and women globally. The historical treatments for this virus have been long, cumbersome, and laden with horrible side effects. The newest drug in our armamentarium, Sovaldi (sofosbuvir), offers the promise of considerably shortening therapy regimens although, at the same time, enhancing remedy response. In brief, this is a wonder drug that we all should be grateful to scientists for creating and pharmaceutical organizations for funding.

English: Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Courtesy of the Center for the Examine of Hepatitis C, The Rockefeller University. (Photograph credit: Wikipedia)

Sovaldi was the end result of the meticulous efforts of pharmaceutical company researchers and their collaborators. Once developed, it was place by way of rigorous and pricey and cumbersome FDA-sanctioned clinical trials prior to being approved—an onerous method that is estimated to cost in excess of $ one billion (not incorporated in the expense is the blind alleys that might have been followed to get to Sovaldi). As this kind of, Sovaldi is a solution of great mental hard work coupled to the assumption of considerable financial danger.

To these whom Sovaldi is prescribed it can be a miracle drug that, in weeks, can rescue one’s life from the perils of continual liver illness. It also has the potential to considerably decrease the potential require for liver transplantation and also lower the general burden of hepatitis C in the population, thereby lessening the opportunity of transmission occasions.

However, not every person shares my sentiment relating to this drug as evidenced by the latest outcry more than the price of this extremely efficacious and novel therapy.  In truth, what has been labeled as a “public shaming” more than the value by insurance coverage companies, healthcare advocates, and patient activists has translated into action as the WHO-convened Planet Wellness Assembly voted to support “flexibility” in intellectual residence rights when it comes to this novel drug giving sanction for countries to break patents if the price tag charged is deemed also high.

The fact that there is controversy in excess of the price tag set for this drug reveals a severe misunderstanding or evasion of the information of manufacturing. Sovaldi does not grow on trees it is not manna from the heavens. Sovaldi is the outcome of work and investment. As this kind of, those that created it and funded it deserve to charge what ever value the marketplace will bear. For, if not for their efforts, it would not exist. Sovaldi is not neighborhood residence but the intellectual home of Gilead.

Treating these discoveries and merchandise as community residence creates an surroundings in which I wonder why this kind of endeavors would ever be undertaken if, when productive, they can basically be confiscated in the identify of the nebulous collective excellent.

Just before the invention of Solvadi, no quantity of money could have produced it available.  It was priceless. To bemoan its cost is to denigrate the minds of people who manufactured such a product obtainable.

The Cost is Correct: New Hepatitis C Drug is Truly a Priceless Breakthrough

The genuine explanation medicines cost so considerably and why huge pharmaceuticals are so rich | Molly Scott Cato

A laboratory at GlaxoSmithKline: Revenue are ‘the reward to the organization for investing in analysis … without this kind of an incentive new medication would not be invented’. Photograph: Sipa Press/Rex

This morning we heard of the row amongst the drug company Roche and the government’s drug adviser, the National Institute for Wellness and Care Excellence (Good), apparently negotiating more than the last six months of the lives of women suffering from breast cancer. At situation was the £90,000 per patient that Roche is charging for the drug Kadcyla, which is not a remedy but can lengthen lifestyle. Protected by what are recognized as intellectual property rights, the firm has a legally sanctioned monopoly and is free to set its cost. This approach is a game of chicken amongst the business and the government, which is subject to lobbying by desperate families but also restrained by a constrained budget.

Pharmaceutical organizations can extract massive revenue by controlling understanding about how to make their medicines. Economic theory about industry competition would recommend that, on seeing the massive income being made, other producers would enter the market and produce the drug a lot more cheaply. This is precisely what manufacturing organizations have been carrying out in current many years, especially in India, offering generic medication to individuals in the world’s poorer nations. But this has been challenged by large pharmaceutical companies, which use their intellectual property rights to constrain the operation of market forces to their benefit, and to the disadvantage of the world’s bad.

The 1st test case of the rights of companies to revenue v the rights of the world’s folks to lifestyle was fought in South Africa in the late 1990s. At that time as numerous as a quarter of its individuals of working age were HIV good, and the government determined to disregard global law and import generic Aids medication from India. The value variation remains staggering – $ 350 for a year’s provide compared with $ ten,000 for the branded medicines – so a bad nation like South Africa had little choice.

South Africa was able to justify its actions under clauses in the trade-related intellectual house rights (Journeys) agreement exempting nations that encounter public well being disasters, but its actions have been challenged by the US trade representative and action was taken against the South African government by the Pharmaceutical Makers Association of South Africa. The government’s courage was rewarded and the situation was ultimately withdrawn in 2001, with the agreement of a deal on sensible pricing and availability of Aids medicines.

The lack of a free marketplace in pharmaceuticals puts pressure on health systems in richer economies as well, due to the fact the price variations are large: the British Generic Companies Association says: “The average price to the NHS of a generic medicine is £3.79, while the regular value of a branded medication is £19.73.” The distinction of £16 is the reward to the organization for investing in analysis and improvement. The argument for this suspension of normal marketplace forces is that with out this kind of an incentive new medication would not be invented.

The row between the United kingdom government and Roche implies that this argument is beginning to unravel, but it also factors towards the underlying dilemma: the lack of true competition. Whilst the rhetoric of totally free markets is much more widespread than ever, the actuality has been an rising degree of consolidation in recent years. The alliance in between Novartis and GlaxoSmithKline is the latest instance, followed swiftly by the AstraZeneca bid for Pfizer.

And the difficulty of market place consolidation and corporate electrical power is not constrained to the pharmaceutical sector. Just last week, the German publisher Axel Springer accused Google of in search of to set up a “digital superstate” and there was also speculation about a merger between the beer giants SABMiller and AB InBev. February, meanwhile, saw the merger of banana giants Fyffes and Chiquita.

The trade talks taking place amongst the EU and US might additional diminish the electrical power of national governments to control consolidation: the draft Transatlantic Trade and Investment Partnership is explained to threaten governments with damages if they introduce legislation that may undermine the returns corporations count on to obtain from their investments within national territories. Enforcement of industry competition and anti-believe in action may possibly be liable to legal action.

Health commentators appear to have been distracted by the debate about privatisation from looking too closely at the industry power of huge pharmaceuticals. Individuals who care about wellness and freedom – dammit, even these who care about a working capitalist economic system and fair competitors – ought to be raising a lot more questions about the way our medication are produced and how the expertise over existence and death is owned and managed.

The genuine explanation medicines cost so considerably and why huge pharmaceuticals are so rich | Molly Scott Cato

Breast cancer drug turned down for NHS use due to substantial cost

A new drug for breast cancer which extends women’s lives by almost 6 months is to be blocked from regimen NHS entry under draft guidance issued by a overall health watchdog. Photograph: Rui Vieira/PA

A Herceptin-type drug that can provide some ladies with advanced breast cancer nearly six months of further daily life has been turned down for use in the NHS since of its substantial value.

In draft guidance now open to consultation, the Nationwide Institute for Wellness and Care Excellence (Great) blames the makers, Roche, who are asking for much more than £90,000 per patient, which is far more than any comparable treatment.

But the determination was criticised by Roche and some breast cancer charities, which say the drug is required and that Nice has turned down as well several breast cancer drugs previously.

The drug, referred to as Kadcyla (generic identify trastuzumab emtansine), is already getting paid for through the committed Cancer Medicines Fund set up by the government. A selection was produced to fund it so that ladies with innovative breast cancer could get it right away it was obtainable, without waiting for Nice’s assessment.

But the Wonderful verdict raises concerns about the future of this kind of pricey cancer medication as soon as the fund ceases to exist at the finish of March 2016. At that level, a new pricing scheme for the NHS is meant to be in location, but Nice will nonetheless assess no matter whether a drug is worth the value the manufacturer desires for it.

Kadcyla is a new kind of medicine, in accordance to Roche, combining Herceptin (trastuzumab) with a chemotherapy agent. It is developed for ladies with HER2+ cancer which has spread to other parts of the physique and is inoperable.

It is not a remedy, but in trials it extended life by a median of five.eight months, in contrast with the existing combination of lapatinib plus capecitabine.

Good says the drug does not perform well sufficient to justify the value tag and known as on Roche to rethink throughout the consultation period.

“We had hoped that Roche would have recognised the challenge the NHS faces in managing the adoption of pricey new treatments by lowering the price of Kadcyla to the NHS,” explained Nice chief executive Sir Andrew Dillon.

“This drug is already currently being funded through the special Cancer Medicines Fund. Our task is to recommend whether or not it ought to transfer into the NHS spending budget. We are very conscious of the relevance that people area on life-extending cancer drugs and a choice not to suggest a cancer remedy for routine NHS funding is in no way taken lightly.

“We apply as a lot versatility as we can in approving new treatment options, but the reality is that offered its cost and what it gives to patients, it will displace more wellness advantage which the NHS could accomplish in other ways, than it will offer you to individuals with breast cancer.”

The value of Kadcyla is tens of 1000′s of pounds more than present second-line treatment options for this cancer, explained Great.

Professor Paul Ellis, a consultant oncologist at King’s University, London, who worked on the drug trials, stated in a statement issued by Roche that it “represents a considerable advance in HER2-positive breast cancer, so for Good to situation damaging preliminary guidance is a enormous blow.

“The drug tackles the disease in a different way to any other breast cancer medication and gives women with useful further time with their families and loved ones – time that you are not able to put a value on. Not only this, Kadcyla is also a lot far better tolerated by females than recent regular treatment choices, triggering significantly significantly less in the way of classic chemotherapy linked side results. As this kind of, the good quality of daily life of girls taking Kadcyla is significantly enhanced.The excellent news is that individuals in England will even now be ready to access this remedy through the Cancer Drugs Fund, but we are keen to discover a a lot more permanent way to successfully assess the value of this kind of medication to make certain people who need to have them most can benefit from them.”

Jayson Dallas, general manager of Roche Products Limited, mentioned the organization was “really disappointed that Wonderful has failed to safeguard the interests of individuals with this sophisticated stage of aggressive ailment”.

Emma Pennery, clinical director at Breast Cancer Care, stated: “It is really disappointing information for people living with superior breast cancer and their families that nevertheless yet another treatment method has not been recommended by Nice.”

Yet another patient group, Breakthrough Breast Cancer said Kadcyla was a very remarkable drug but known as for alterations to the expense of medicines as properly as the appraisal method. “We are now seeking to the Department of Health and the pharmaceutical sector to locate a way to operate collectively to deliver the cost of pricey medication down and place a sustainable system in area by which new therapies can be manufactured offered on the NHS on a program basis,” explained senior policy manager, Dr Caitlin Palframan.

About one,000 ladies a month die of superior breast cancer, despite the fact that not all of them have the HER2+ selection which the drug targets.

A spokesperson for NHS England explained: “The Cancer Medicines Fund (CDF) gives an further £200m every single yr to allow sufferers to access medicines that are not routinely funded by the NHS. A variety of the drugs obtainable to sufferers through the CDF have previously been appraised by Nice and are not suggested for schedule use. It was for this goal that the CDF was established.

“A negative Great appraisal on trastuzumab emtansine will not affect the availability of this drug by way of the Cancer Drugs Fund.”

Breast cancer drug turned down for NHS use due to substantial cost

Avoiding Healthcare Cost With Pricing Transparency Hype

No less than two reports have been published final week which fall loosely underneath the banner of healthcare pricing transparency.

The 1st was Medscape’s Physician Compensation Report for 2014 (right here). The annual Medscape report is based mostly on a survey of in excess of 24,000 physicians in 25 specialties around a broad range of compensation troubles – including satisfaction.

Medscape’s findings (with data from 2013) is marginally far more insightful than the Medicare Information dump from 2 weeks in the past (here). 1 of glaring inadequacies of the Medicare data (for 2012) is the simple reality that income isn’t compensation. Seeing an annual summary of what Medicare paid to individual suppliers has practically no patient use.

In accordance to the Medscape report (slides right here) there weren’t many big swings in compensation (there seldom are), but there’s usually a few noteworthy shifts. No significantly less than 19 of the 25 various practice regions noticed an improve in compensation from the prior year, 1 was neutral and five saw a decrease. Of the decreases, only 1 (nephrology) saw an 8% decline in compensation. Three of the remaining four saw a 2% decline.

All round satisfaction was close to or over 50% for most of the specialties across 4 categories (Total, Income, Career and Specialty). The two noteworthy exceptions have been Loved ones &amp Internal Medication with 32% and 27% (respectively for decision of specialty) even even though they appeared to be comparatively content (50% &amp 46%) with their income. Other findings as quoted from the slide notes:

• Those who carry out procedures have the highest incomes compared with individuals who manage chronic illnesses. Earnings are for total-time function only. They include salary, bonus, and profit-sharing contributions. They do not consist of non-patient-connected earnings.


• In this year’s Medscape report, the perception of being relatively compensated does not correlate to real compensation for several doctors. Orthopedists had been the most hugely paid physicians, but they fell under the middle of this record, with only 45% believing that they are fairly compensated. And despite the fact that plastic surgeons were seventh between the leading earners, at 37% they have been the least most likely of all physicians to think that they are fairly paid.


• When evaluating newer payment versions with survey results from 2011, there has been a dramatic rise in doctors choosing ACOs, with 24% of all doctors now employed in these organizations vs only 3% in 2011. Moreover, ten% are planning on joining this yr. In spite of considerable publicity, income-only and concierge practices are nonetheless not significant payment designs.


• 5% of employed and 15% of self-employed doctors explained that they will not get new Medicare or Medicaid patients.


• Although Medicare is known to have lowered fees, private insurers are also paying less, especially to modest practices without having any strong influence. Robert Morrow, MD, a family members physician in the Bronx and a Medscape advisor, mentioned he now receives $ 82 from Medicare for an office visit but only about $ 45 from commercial insurers.


• About 72% of respondents to this survey routinely or sometimes go over the expense of treatment method with individuals. This has gone up from 68% in 2012.


• 35% of employed doctors devote at least ten hrs a week on paperwork compared with 26% of the self-employed.

The second report – Price Transparency in Overall health Care (PDF right here) – was from the Healthcare Financial Management Association (HFMA). For people unfamiliar with HFMA, their site (right here) describes the organization this way:

HFMA is the nation’s top membership organization for healthcare monetary management executives and leaders. More than forty,000 members-ranging from CFOs to controllers to accountants-consider HFMA a respected believed leader on best trends and troubles dealing with the healthcare industry. 

In fairness, they exclusively indicate that the “primary audience for this report is sector stakeholders in provider, payer, and purchaser settings that this report calls upon to take distinct actions to improve the transparency of healthcare prices” (ie: not customers or sufferers).

The conclusion from HFMA’s 20-page report is just this:

The lack of price transparency in well being care threatens to erode public believe in in our healthcare system, but this erosion can be stopped. Sufferers are assuming greater financial accountability for their healthcare needs and in turn need the data that will permit them to make informed healthcare selections. Price is not the only details needed to make these selections as this report has mentioned, cost must be presented in the context of other relevant data on the quality of care. But it is an important element. The time for price transparency in well being care is now.

I have grave doubts about stopping the erosion of public trust. Two of the seven headings are “Guiding Ideas for Value Transparency” and “Recommendations for Price tag Transparency Frameworks.” In impact, it’s generally another market “call to action.”

Sadly, the worth of any of this “transparency” is truly marginal – either in terms of our own actions – or in terms of the influence on our Nationwide Healthcare Expenditure (NHE). The Centers for Medicare and Medicaid (CMS) forecasts our NHE to be $ 3.1 trillion this 12 months. In reality, our NHE as forecasted by CMS (Table one web page five right here) seems to be like this through 2022 (the two with and without Obamacare).

All of which tends to make this type of transparency comparable to rubbernecking a freeway accident. There’s a short minute of anxiousness and tension and then everyone speeds on their way. Assuming data accuracy, releasing any healthcare pricing is a hollow objective because there is virtually nothing at all any person can do with it. We merely have no way to influence it – either individually or collectively – and absent quality (or clinical outcomes), there is no way to equate any worth. We may possibly as properly use random amount generators.

The 1 point it constantly does, nonetheless, is to highlight how significantly our healthcare program is optimized all around income and earnings. Possibly someday this will translate into a debate about real healthcare reform – the one we continually keep away from (cough – SGR / “doc fix” – cough). That debate is not called transparent anything. Its known as healthcare cost.

Avoiding Healthcare Cost With Pricing Transparency Hype

How Obamacare Lowers The Cost Of Your Automobile Insurance coverage

The cost of car insurance coverage, workers’ compensation coverage and general organization liability insurance coverage could drop by as considerably as five% thanks to the Affordable Care Act, according to a new examine.

Even though the overall health law doesn’t cover vehicles or staff compensation, new evaluation by RAND Corporation indicates it may possibly support vehicle owners and organizations with workers’ compensation coverage since people premiums often go towards treating people’s injuries, especially these with out health care coverage.

Liability insurance businesses reimburse “tens of billions of dollars” every 12 months for healthcare care connected to auto accidents, workplace injuries and connected claims, RAND researchers say. Automobile insurers paid $ 35 billion for “medical costs related with accidents in 2007,” RAND says, saying that totaled about two% of all overall health care costs that yr.

“Under affordable assumptions, some effects can produce potential value modifications as high as 5% or much more in specified states and for particular insurance coverage lines,” Rand researchers Paul Heaton and Ian Brantley publish in their review summary. “Most are in the unfavorable (cost-minimizing) path. In the case of the personal substation effect, liability insurers are, right now, paying out for some of the additional charges connected with treating the uninsured.”

Jayne Plunkett, head of casualty reinsurance for Swiss Re Swiss Re, a reinsurance organization that sponsored the study, says the examine shines light on “the far-reaching impacts of the Affordable Care Act.”

“Businesses and policymakers need to recognize how and why their risk profiles may well alter as the Affordable Care Act is implemented,” Plunkett says in a statement accompanying the RAND report.

While car premiums and other kinds of coverage could go down, researchers caution that health-related liability coverage could go up. For instance, RAND researchers mentioned an escalating variety of people making use of the wellness care method may possibly trigger an enhance in the amount of malpractice claims towards medical doctors and hospitals.

More than 7 million Americans signed up for coverage on government-run marketplaces to wellness plans operated by an array of private ideas offered by Aetna Aetna, Humana Humana, UnitedHealth Group UnitedHealth Group and most Blue Cross and Blue Shield strategies. In addition a lot more than three million Americans have signed up for Medicaid wellness insurance for the poor, which was also expanded underneath the health law.

“The Affordable Care Act is unlikely to significantly have an effect on liability fees, but it could influence modest and moderate modifications in fees above the following several many years,” says David Auerbach, the study’s lead author and a policy researcher at RAND, a nonprofit study organization. “For example, car insurers could devote significantly less for treating injuries, even though it could price a bit far more to supply physicians with health-related malpractice coverage.”

How Obamacare Lowers The Cost Of Your Automobile Insurance coverage

Britain faces meals cost rises, floods and deadly heatwaves as a outcome of climate adjust

Warming by 4C (seven.2F) from pre-industrial ranges will lead to a “fundamentally different” globe from today – whereas limiting warming to 2C (three.6F) by cutting emissions will outcome in a world “not dramatically different” from right now, Chris Area, co-chair of the IPCC functioning group that authored the report.

“With large levels of warming that result from continued development in greenhouse fuel emissions, dangers will be demanding to handle, and even significant, sustained investments in adaptation will encounter limits,” he explained.

Ed Davey, Britain’s vitality and climate adjust secretary, said the report showed that “left unchecked, climate modify will have far reaching consequences for our society” and vindicated the government’s drive to go green.

“This evidence builds the case for early action in the United kingdom and close to the globe to reduce the dangers posed by climate modify,” he said. “We can not afford to wait.”

The IPCC’s report into “Impact, Adaptation and Vulnerability” brings together the work of hundreds of climate scientists around the world.

It concludes the impacts of climate adjust are currently evident nevertheless several parts of the world are “ill-prepared for the risks” it brings.

“Investments in far better planning can pay dividends for the two the current and the potential,” Vicente Barros, co-chair of the functioning group, said.

Britain is reasonably properly-positioned to be in a position to adapt to climate modify but requirements to consider action to do so, authors of the report mentioned ahead of its formal launch in Japan.

“The sea level is increasing, so we know that the risk of flooding on the coastal zone is going to boost,” Nigel Arnell of the University of Reading through Walker Institute, stated.

“We know temperatures are rising, so we know the danger of heatwaves and prolonged hot spells are going to improve, and we know the implications of individuals in our cities and for crop production.

“We strongly suspect climate alter will influence on the reliability of our water supply methods. And we really strongly suspect that climate change will make flooding along our rivers and in our modest catchments a lot more frequent.”

Climate alter is also probably to hit crop production globally, resulting in “instability and volatility of worldwide food prices”, Neil Adger of the University of Exeter’s School of Life and Surroundings Sciences explained.

“Britain is not immune from the global trends in the way worldwide agricultural markets are set up.”

Cities are most likely to be particularly badly impacted by climate change simply because the dense population exacerbates other risks, and elderly folks are most likely to be specifically affected by heatwaves.

“In Britain we not very very good at adapting to heatwaves. Individuals who are vulnerable to heatwaves are physiologically vulnerable to them. They frequently influence the elderly,” he mentioned, describing present strategies to support elderly cope with extreme heat as “not very effective”.

Climate controversy

The IPCC’s report into the impacts of climate alter threatens to be overshadowed by a row in between its authors above its findings.

Richard Tol, a scientist who was a lead writer on a section of the report dealing with the economic results of international warming, last week claimed the report’s conclusions were “also alarmist”.

But Chris Field, the co-chair of the report, hit back yesterday saying that Tol’s very own analysis was “outdated-fashioned” and had contained “mistakes”.

A leaked draft of the suggestions to policymakers explained that “global indicate temperature increases of 2.5C above preindustrial amounts may lead to worldwide aggregate financial losses among .2 and 2 per cent of income”, in line with Tol’s views.

But critics argued the prediction underplayed the very likely affect. In the ultimate version, the section has been substantially rewritten. It now says that “global financial impacts from climate modify are tough to estimate” and heavily caveats the .2 to 2pc forecast.

Discipline explained: “There had been a couple of meaningful mistakes in the way Richard had completed his evaluation and as a consequence of mindful work in the final couple of week we have come up with a much better way of considering about them, a more accurate way.”

“Richard Tol is a fantastic scientist but.. he is sort of out on the fringe. When you truly seem at in which we are with modern day science I feel individuals .2-2pc numbers are truly previous-fashioned.”

Tol advised the Telegraph: “The Technical Assistance Unit mentioned one error correcting it did not considerably modify the conclusions.”

Britain faces meals cost rises, floods and deadly heatwaves as a outcome of climate adjust

Doctors" fears over statins may cost lives, says top medical researcher

Physicians worrying about the safety of cholesterol-lowering statins are generating a misleading level of uncertainty that could lead to the reduction of lives, in accordance to a single of the UK’s major healthcare academics.

Professor Sir Rory Collins, from Oxford University, explained he believes GPs and the public are getting produced unjustifiably suspicious of the drug, generating a scenario that has echoes of the MMR vaccine controversy.

The academic, one particular of the country’s major experts on the drug, is notably unhappy with the British Health-related Journal (BMJ), which has run nicely-publicised posts by two critics of statins that he argues are flawed and misleading.

“It is a serious disservice to British and global medication,” he said, claiming that it was probably killing more men and women than had been harmed as a outcome of the paper on the MMR vaccine by Andrew Wakefield. “I would feel the papers on statins are far worse in terms of the harm they have completed.”

Interactive: how statins work

Interactive: how statins work

A swift guidebook to how statins lessen the manufacturing of ‘bad’ LDL cholesterol in the reside

Statins are presently currently being taken in the Uk by seven million folks who have at least a 20% risk of a heart assault or stroke in the up coming 10 many years. Following a main study overseen by Collins’ group at Oxford in 2012, the National Institute for Health and Care Excellence (Wonderful) advisable in February that they should be provided to men and women at only 10% chance – potentially dramatically growing the number of people taking them.

A variety of medical professionals are amongst individuals who have questioned the wisdom of dosing basically healthy men and women to avert – rather than deal with – sickness. Some of them doubt the information from the drug organization trials, which has been manufactured obtainable to Collins and his group but to no one else.

Collins criticised two papers published by the BMJ – 1 by John Abramson, a clinician doing work at Harvard healthcare college, and the other by Aseem Malhotra, a cardiologist in the United kingdom. The two physicians said statins did not reduce mortality and that side results meant they did a lot more harm than good.

The Oxford academic stated the side-impact claims were misleading and specifically damaging since they eroded public self confidence. “We have truly great information from in excess of one hundred,000 men and women that demonstrate that the statins are really well tolerated. There are only one particular or two properly-documented [problematic] side results.” Myopathy, or muscle weakness, occurred in one particular in 10,000 people, he stated, and there was a tiny enhance in diabetes.

But the two researchers criticised by Collins mentioned the side effects were true, with one accusing the professor of “fear-mongering”.

Abramson stated the examination by him and his staff, published in the BMJ, showed statins did not considerably minimize mortality in the twenty% or ten% threat groups. “This raises two problems,” Abramson said. “First, Dr Collins is fear-mongering when he says that ‘lives will be lost’ as a outcome of our calculations. 2nd, if Dr Collins believes our analysis is not correct, then he must release the patient-degree data … so this discussion can be primarily based on direct evaluation of the data rather than relying on their representation of the manufacturers’ information. At this point, I feel there is no excuse for not producing this data public and the ongoing secrecy only raises the public’s degree of suspicion.”

Though Malhotra accepted the positive aspects of statins for people who presently had heart illness and prescibed them for this kind of sufferers, he stated “prescribing them to a reduced-chance group, possibly placing hundreds of thousands a lot more of the Uk population [on statins] would in my see be a public overall health disaster, contributing to continual suffering to sufferers and putting a wonderful strain on the NHS”.

The data did not demonstrate that statins prevented death or serious illness in individuals at minimal threat, he mentioned. “Real globe information also reveal that up to 20% of individuals endure disabling side results that consequence in discontinuation of the drug. The side results incorporate fatigue, muscle discomfort, abdomen complaints, quick-phrase memory reduction, and erectile dysfunction.”

Dr Fiona Godlee, editor of the BMJ, said main issues had been raised in the papers that deserved public debate – notably the potential medicalisation of a massive proportion of the population and the lack of accessibility to data held by drug organizations. Even though Collins had seen the complete data, Ebrahim and the Cochrane collaboration had not. “To rely on one meta-examination by one particular group is no longer acceptable,” she mentioned.

She dismissed Collins’ suggestion that there was a similarity amongst the BMJ’s publication of the statin papers and the Lancet’s 1997 choice to publish the controversial paper by Andrew Wakefield that wrongly suggested a hyperlink among MMR and autism.

“This is a debate that has been ongoing – the BMJ did not start it. Extending the statins to healthful folks at reduced risk is an enormously essential selection which should be topic to debate and question.”

The BMJ had currently invited Collins to compose a critique of the papers for publication, she additional.

A review two weeks in the past in the European Journal of Preventive Cardiology, which looked at drug company trial information, located that as a lot of individuals knowledgeable side results on placebo dummy tablets as on the statins. Dr Ben Goldacre, a single of the authors of the research, mentioned participants could have seasoned the “nocebo” result – exactly where individuals think they are experiencing the side effects they have heard the drugs may induce. But the flaw in the study, he explained, was that the authors did not have accessibility to the complete data from the pharmaceutical firms behind the medicines.

‘I suffered horrible aching limbs’

Claire Rumble suffered aching limbs when she started taking statins to management her cholesterol level. Photograph: Dimitris Legakis/Athena Images

Claire Rumble has knowledgeable each sides of the coin when it comes to the side results of statins.

The 47-12 months-old, from Llanelli, Wales, was place on a cholesterol-lowering drug following getting three heart attacks inside 36 hrs in 2009. The diagnosis was a blocked artery and regardless of her cholesterol not currently being specifically large, the consultant said that she should commence taking statins. Rumble was prescribed Simvastatin but, as with others who have reported side effects from making use of statins, she created muscle pains.

“I suffered horrible aching limbs,” she recalled. “I acquired it for 6 to eight months. I considered my entire body was adapting to the tablets. My arms and legs just felt quite heavy, it could make you really feel really fluey.”

Right after the aches failed to disappear, Rumble, a fundraiser for Hafan Dda NHS trust and supporter of the British Heart Basis, went back to the medical professional, who put her on a diverse statin, Rosuvastatin.

“Within days of shifting, I felt a lot a lot greater and haven’t had a day’s problem since. I would suggest that if you are struggling aching muscle groups, go and see your GP and change [your medication],” she said.

In spite of her troubles with Simvastatin, Rumble is philosophical. “Maybe Simvastatin wasn’t ideal for myself but I’m positive several individuals could take it with no going through side effects.”

As if to show her point, Susan Saul, an insulin-dependent diabetic from Stanmore, north-west London, had a entirely diverse encounter with the same two medicines.

With a historical past of large cholesterol and heart difficulties in her household, Saul was prescribed Simvastatin far more than ten many years in the past as a precaution. But after about a yr she was moved on to Rosuvastatin, in the belief that it may possibly be more successful. “Within a couple of days I noticed I was getting really extreme leg cramps,” explained Saul, a supporter of Heart Uk. “It was awful, largely at night.”

She study the accompanying leaflet which identified her signs as a possible, if unusual, side effect. “I persevered for about two weeks but if something they have been receiving much more regular and extreme. I acquired changed back to the original [Simvastatin] and they went away almost quickly.” Saul mentioned she has experienced no problems since.

The study from Imperial School London’s Nationwide Heart and Lung Institute that prompted the side-effects row recommended that some of the ailments suffered by statins consumers have been not as a consequence of the drugs, but Saul believes her cramps had been.

“My feeling on statins is that, as with any drug, various medicines suit distinct men and women,” she explained. “You have side results with any medication. Every time I go to my diabetes clinic and get my cholesterol checked, if it is gone down additional, I believe the statins are doing the task, they are operating. I think the benefits outweigh the risks.”

Doctors" fears over statins may cost lives, says top medical researcher

Britain"s dental cost lottery - and how to pay out much less in your postcode

Root canal treatment method in Stockport would expense £595, but just £85 in Swindon.

^{For a greater edition of this table, and other people, see the slideshow of pictures over. Supply: WhatClinic.com}

The stark variations in expenses are very likely down to the “lack of transparency in dentistry” a spokesman for WhatClinic explained. “The market place is not effective, and like all inefficient markets, cost discrepancy is designed by a lack of expertise by the two the consumer and the companies offering the providers.

“The way factors stand, sufferers really don’t tend to shop all around. And that signifies there is quite little incentive for the practice owner to price competitively.”

Caelen King, CEO of WhatClinic, advises folks looking for personal dental treatment method to go on the web to check out the costs of dentists in their area, as the expenses can fluctuate substantially between clinics in the very same city or town. “Just paying a number of minutes on-line evaluating regional prices could conserve you a significant quantity of cash above the course of a year,” he mentioned.

Not only are there massive variations in accordance to the place in the Uk the dentist is, but the price of personal dental care versus NHS dental care differs substantially as nicely.

Unless of course you are eligible for free NHS dental care – individuals on positive aspects, pregnant girls, and people underneath-18 – then you have to spend for any dental remedy you get, even if it is “through the NHS”. Most dentists provide the two NHS and personal treatment to patients. Crucial dental treatment ought to usually be offered at NHS prices, if the practice does NHS work, but you will be asked to spend for non-essential operate privately. Teeth-whitening, for illustration, is only offered privately as it is cosmetic. Your dentist must always make clear if treatment will be charged at a private or NHS price.

Remedies underneath the NHS have managed charges. As of April 2013, the cost of NHS dental therapies were categorised into 3 bands. Band one particular is the cheapest, at £18, which covers mouth and teeth examination, diagnosis, and advice. Band two charges £49, and patients will get all of the procedures integrated in band one, plus remedies such as fillings, root canal work and tooth extraction. Band three expenses £214, and covers every little thing listed in the initial two bands, as nicely as crowns, dentures and bridges.

Consumers have prolonged been muddled about the big difference among NHS and private therapy and their respective costs. In 2012, the Office of Honest Trading launched an investigation into the £5.73bn Uk dental industry. It identified, among other factors, that individuals had insufficient information to make decisions about their option of dentist and remedies. In accordance to the report, 39pc of NHS dental patients who had been to the dentist in the prior two years said that there had been no leaflets or posters delivering details on NHS fees at their dentist. As a outcome, a lot of patients have been paying out much more to obtain private dental care.

The British Dental Overall health Basis estimates that 63pc of adults use NHS services for price reasons, although 19pc of Britons delay remedy simply because of the price, so cost is obviously an concern.

This is why thousands of individuals go abroad each year for less expensive private remedy. The dental travel operator Dentist Abroad estimates that more than 70,000 Britons a year do so, in search of greater prices.

The internet site promotes Budapest as the area to get low-cost dental care, with the price of root canal treatment method from £120, in contrast to £250 in the United kingdom, and veneers for £320 compared to £450.

But the cost savings can sour if, on return home, patients require even more perform or have to place things proper. In a survey by the British Dental Association (BDA), 29pc of Uk dentists reported possessing had to treat individuals for problems arising from treatment method abroad.

Dr John Milne of the BDA explained: “Patients taking into consideration dental treatment method overseas ought to check a dentist’s qualifications and encounter and regardless of whether or not they are insured if things go wrong, as regulation is not often as rigid as it is in the Uk.

“Complex, high-priced programs of therapy generally demand thorough planning and a number of follow-up visits. The patient should be conscious of the dangers and options to the treatment method sought after, and get suggestions on what they must do in the occasion of problems taking place when they return to the Uk.”

You can uncover out about wellness regulators and specialist bodies in other nations by visiting healthregulation.org.

The Standard Dental Council says: “We suggest you do as a lot research as you can and find out the details before you go to make sure your treatment method abroad meets your expectations.”

Britain"s dental cost lottery - and how to pay out much less in your postcode

Mental wellness problems "cost Uk £70bn a year", claims thinktank

An OECD research identified that the bill to the Uk from a failure to cope adequately with mental wellness concerns was 4.five% of GDP every year. Photograph: Jonathan Nourok/Getty Photographs

Psychological wellness issues are costing Britain £70bn a yr, the west’s leading economic thinktank explained on Monday, as it urged the government to help those with depression, pressure and nervousness into operate. The Paris-primarily based Organisation for Economic Co-operation and Improvement explained psychological overall health was the cause of 40% of the 370,000 new claims for disability advantage every single year – the highest recorded among the 34 nations that belong to the so-known as “rich man’s club”.

An OECD review found that the bill to the Uk from a failure to cope adequately with psychological overall health issues was 4.5% of GDP each year, caused by productivity losses, larger advantage payments and the improved expense to the NHS.

“Greater policies and practices by employers and the wellness technique are needed to support men and women deal with mental wellness concerns and get back to operate,” the OECD explained.

It extra that close to 1 million claimants on employment and help allowance (ESA), and as many on jobseeker’s allowance (JSA) and other functioning-age positive aspects, had a psychological disorder such as anxiousness and depression that was hurting their prospects of obtaining work.

And it warned that individuals with psychological wellness problems could be further disadvantaged by the welfare cuts unless of course the Government did far more to assist their operate prospects.

“Some of the recent United kingdom welfare reforms designed to tackle stubbornly large disability benefit caseloads go in the proper course. Even so, further improvements are required to make sure that reforms reside up to their guarantee to bring people into perform. If welfare cuts are to be made, they need to be matched by increased efforts to tackle the barriers to obtaining and remaining in perform,” stated the report.

“The new Work Programme is struggling to area ESA and JSA claimants with mental overall health problems into work”, the OECD stated. “People with a psychological illness carry on to fare badly compared to their counterparts with no such illness: their unemployment charge is far more than double the general rate and the threat of falling below the poverty threshold is nearly double the total danger. Indeed, the chance of poverty amongst men and women with mental health difficulties is the highest in a comparison of ten OECD countries like seven other European countries, Australia and the US.”

Noting that prevention was better than remedy, the OECD listed a series of suggestions for the United kingdom, such as a more powerful focus of psychological well being in the workplace an improve in assets for employment support companies to guarantee far more people with mental concerns discovered jobs better integrations of wellness and employment providers: and enhanced access to psychological therapies for people with a widespread mental disorder.

Norman Lamb, Care and Assistance Minister stated: “People with mental overall health circumstances can and do operate and the huge bulk want to. That’s why last summertime, doing work with the Department for Perform and Pensions, we jointly commissioned a report to look at how we can far better support individuals with psychological wellness issues to get back to and keep in function. This could not only support them, but helps to create a more powerful economic climate and decrease the strain on the positive aspects technique.

“Progress has presently been manufactured — the expanding Bettering Accessibility to Psychological Therapies programme has already assisted above 80,000 people to move off sick shell out and benefits. We are vigorously pursuing options and are working across Government to drive improvements. The OECD has recognised the successes we have had, but we want to go further.”

Mental wellness problems "cost Uk £70bn a year", claims thinktank

Retendering NHS 111 contracts could cost millions

111 line replaced NHS Direct as the amount to phone for urgent but non-emergency care. Photograph: Alamy

The bungled launch of the NHS 111 support is likely to cost the health service millions of pounds, in accordance to an investigation by the British Health-related Journal (BMJ).

The services was thrown into turmoil last July soon after one particular of the major providers, NHS Direct, announced it planned to pull out of its contracts due to significant monetary troubles.

The price of retendering the contracts is most likely to be really high, the BMJ stated. In just a single region impacted, the West Midlands, the reprocurement approach will cost £500,000, it located.

The NHS 111 line, which replaced NHS Direct as the number to phone for urgent but non-emergency care, has been riddled with teething issues considering that its inception on 1 April. Sufferers have complained of calls going unanswered, bad suggestions offered and calls getting diverted to the wrong part of the nation.

A month following the launch, leading medics mentioned the “problematic” roll-out of the technique had left several patients not being aware of in which to flip. NHS England launched an investigation into the tips line right after a quantity of incidents, like 3 deaths, have been linked to the support.

NHS Direct initially won 11 of the 46 contracts across England to give the 111 service. But in July it announced it would be unable to provide the service in North Essex, Cornwall, Somerset, Buckinghamshire, east London and the City, south-east London, Sutton and Merton, West Midlands, Lancashire and Cumbria, Greater Manchester, Merseyside and Cheshire.

A spokeswoman for NHS Direct said the contracts, which covered far more than a third of the population of England, have been “financially unsustainable”. In October the organisation announced that it was to close soon after projecting a £26m deficit for this economic 12 months.

Dame Barbara Hakin, chief operating officer at NHS England, mentioned: “NHS 111 is now a steady and improving service and we are assured it will continue to get better. I have been impressed by the way that the employees providing these companies across the country have turned the circumstance all around on behalf of the public.

“NHS 111 gives a excellent services with large levels of public fulfillment. Calls are answered promptly and a lot more individuals are obtaining accessibility to the support as we move to complete coverage in February 2014. The latest urgent care review identified the important role that 111 can play. The concept of calling for suggestions first is crucial for patient care outcomes and we are committed to guaranteeing 111 plays its complete element in this.”

Labour’s shadow wellness minister Andrew Gwynne explained: “It is now clear that ministers wasted hundreds of thousands on flawed contracts. Labour warned the government at the outset that 111 was fundamentally flawed but they pressed ahead with the rollout irrespective.

“David Cameron is responsible for its shambolic introduction. The destruction of NHS Direct – a trusted, national support – is one particular of his worst acts of vandalism.”

Retendering NHS 111 contracts could cost millions